Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
Tamoxifen: No Mortality Benefit For Most “High Risk” Women
This article is from
The Cancer Letter
archive.
Vol. 29 No. 9 | September 29, 2006
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
AACR, ASCO Publish Reports Examining U.S. Cancer Care
April 4, 2014
TCL Archive
DeVita, Greenwald Assure Centers They’ll Get More Money for Cancer Control
May 11, 1984
TCL Archive
“Bring Contracts Under Control, Save $100,00 A Year,” Samuels Tells NCI
November 2, 1979
TCL Archive
Three Nurse Awards Made In Self Care
September 30, 1988
TCL Archive
NCI To Fund More SPORE Grants In FY95 Recopetition
March 11, 1994
TCL Archive
Four Win 1988 General Motors Cancer Prizes
June 17, 1988